Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor κB) activation: Role of arachidonic acid

Molecular Pharmacology

Volumn 51, Issue 6, 1997, Pages 907-912

  Mitchell, Jane A ^a,b   Saunders, Michael ^b   Barnes, Peter J ^b   Newton, Robert ^b   Belvisi, Maria G ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROSTAGLANDIN SYNTHASE; SALICYLATE SODIUM;

ARACHIDONIC ACID METABOLISM; ARTICLE; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATION; PAIN; PRIORITY JOURNAL;

EID: 0030976878     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.6.907     Document Type: Article

References (25)

1. Dreser, H. (1899) Pharmocologisches über Aspirin (Acetylsalicyl-saüre). Pfluegers Arch. Gesamte Physiol. Menschen. Tiere 76:306-318 (1899).
2. Vane, J. R., and Botting, R. M. The mode of action of anti-inflammatory drugs. Postgrad. Med. J. 66:S2-S17 (1991).
3. Vane, J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231:232-235 (1971).
4. Mitchell, J. A., S. Larkin, and T. J. Williams. Cyclooxygenase-2: regulation and relevance in inflammation. Biochem. Pharmacol. 50:1535-1542 (1995).
5. Xie, W., J. G. Chipman, D. L. Robertson, R. L. Erikson, and D. L. Simmons. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Arch. Biochem. Biophys. 300:247-252 (1991).
6. Kujubu, D. A., and H. R. Herschman. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J. Biol. Chem. 267:7991-7994 (1992).
7. Vane, J. R., J. A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall, and D. A. Willoughby. Inducible isoforms of cyclo-oxygenase and nitric oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 91:2046-2050 (1994).
8. Tomlinson, A., I. Appleton, A. R. Moore, D. W. Gilroy, D. Willis, J. A. Mitchell, and D. A. Willoughby. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenan-induced pleurisy. Br. J. Pharmacol. 113:693-698 (1994).
9. Masferrer, J. L., B. S. Zweifel, P. T. Manning, S. D. Hauser, K. M. Leahy, W. G. Smith, P. C. Isakson, and K. Seibert. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA 91:3228-3232 (1994).
10. Mitchell, J. A., P. Akarasereenont, C. Thiemermann, R. J. Flower, and J. R. Vane. Selectivity of nonsteroid anti-inflammatory drugs as inhibitors of constitutive and inducible cyclo-oxygenase. Proc. Natl. Acad. Sci. USA 90:11693-11697 (1993).
11. Meade, E. A., W. L. Smith, and D. L. DeWitt. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268: 6610-6614 (1993).
12. O'Neill, G. P., J. A. Mancini, S. Kargman, J. Yergey, M. Y. Kwan, J. P. Falgueyret, M. Abramovitz, B. P. Kennedy, M. Ouellet, and W. Cromlish. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Mol. Pharmacol. 45: 245-254 (1994).
13. Gierse, J. K., S. D. Hauser, D. P. Creely, C. Koboldt, S. H. Rangwala, P. C. Isakson, and K. Seibert. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem. J. 305: 479-484 (1995).
14. Chan, C. C., S. Boyce, C. Rideau, A. W. Ford-Hutchinson, R. Gordon, D. Guay, R. G. Hill, C. S. Li, J. Mancini, and M. Penneton. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J. Pharmacol. Exp. Ther. 274:1531-1537 (1995).
15. Ouellet, M., and M. D. Percival. Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms. Biochem. J. 306:257-251 (1995)
16. Kopp, E., and S. Ghosh. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science (Washington D. C.) 265:956-959 (1994).
17. De Witt, D. L., E. A. El-Harith, S. A., Kraemer, M. J. Andrews, E. F. Yao, R. L. Arnstrong, and W. L. Smith. The aspirin and heme-binding sites of ovine murine prostaglandin endoperoxide synthases. J. Biol. Chem. 265: 5192-5198 (1990).
18. Whittle, B. J. R., G. A. Higgs, K. E. Eakins, S. Moncada, and J. R. Vane. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature (Lond.) 248:271-273 (1980).
19. Loll, P. J., D. Picot, and R. M. Garavito. The structural basis of aspirin activity inferred from the crystal structure of in activated prostaglandin H2 synthase. Nat. Struct. Biol. 2:637-643 (1995).
20. Mitchell, J. A., M. G. Belvisi, P. Akarasereenont, R. A. Robbins, O. J. Kwon, J. Croxtall, P. J. Barnes, and J. R. Vane. Induction of cyclooxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br. J. Pharmacol. 113:1008-1014 (1994).
21. Newton, R., I. M. Adcock, and P. J. Barnes. Superinduction of NF-kppaB by actinomycin D and cycloheximide in epithelial cells. Biochem. Biophys. Res. Commun. 218:518-523 (1996).
22. Osborn, L., S. Kunkel, and G. J. Nabel. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of nuclear factor kappa B. Proc. Natl. Acad. Sci. USA 86:2336-2340 (1989).
23. 2 in A549 cells. Inflam. Res., in press.
24. Wu, K. K., R. Sanduja, A. L. Tsai, B. Ferhaboglu, and D. S. Loose-Mitchell. Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells. Proc. Natl. Acad. Sci. USA 88:2384-2387 (1991).
25. Higgs, G. A., J. A. Salmon, B. Henderson, and J. R. Vane. Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and anti-inflammatory activity. Proc. Natl. Acad. Sci. USA 84:1417-1420 (1987).